The Food and Drug Administration approved a generic abortion pill.
In a letter to Evita Solutions, the FDA wrote, “We have completed the review of this [new drug application] and have concluded that adequate information has been presented to demonstrate that the drug meets the requirements for approval under the FD&C Act. We have determined your Mifepristone Tablets, 200 mg to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Mifeprex (mifepristone) tablets, 200 mg, of Danco Laboratories, LLC.”
A statement from Evita Solutions says that the “generic mifepristone” can be used “up to 70 days from the first day of the last menstrual period.”
Senator Josh Hawley (R-MO) condemned the approval in a statement on X, writing, “This is shocking. FDA has just approved ANOTHER chemical abortion drug, when the evidence shows chemical abortion drugs are dangerous and even deadly for the mother. And of course 100% lethal to the child.”
“FDA had promised to do a top-to-bottom safety review of the chemical abortion drug, but instead they’ve just greenlighted new versions of it for distribution. I have lost confidence in the leadership at FDA,” he wrote.
Students for Life Action similarly condemned the drug’s approval, stating, in part, “More babies will die; More women will be harmed; and More Americans exposed to Abortion Water Pollution as a direct result of this unfathomable decision. This is a stain on the Trump Presidency and another sign that the deep state at the FDA must go.”
Health and Human Services Secretary Robert F. Kennedy Jr. announced in May that he directed the FDA to conduct a review of the abortion pill.
